Literature DB >> 21672093

Drug use and HIV in West Africa: a neglected epidemic.

Gilles Raguin1, Annie Lepretre, Idrissa Ba, Ibrahim Ndoye, Abdalla Toufik, Gilles Brucker, Pierre-Marie Girard.   

Abstract

Injecting drug use is poorly documented in West Africa. HIV prevalence studies are still rare. Recent studies show that drug injection is on the rise. There is an urgent need to take this component of the HIV epidemic into account and to establish adapted intervention strategies.
© 2011 Blackwell Publishing Ltd.

Mesh：

Year:  2011        PMID： 21672093     DOI： 10.1111/j.1365-3156.2011.02806.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN： 1360-2276            Impact factor:   2.622


  7 in total

1.  Epidemiology of hepatitis B virus and/or hepatitis C virus infections among people living with human immunodeficiency virus in Africa: A systematic review and meta-analysis.

Authors:  Raoul Kenfack-Momo; Sebastien Kenmoe; Guy Roussel Takuissu; Jean Thierry Ebogo-Belobo; Cyprien Kengne-Ndé; Donatien Serge Mbaga; Serges Tchatchouang; Martin Gael Oyono; Josiane Kenfack-Zanguim; Robertine Lontuo Fogang; Chris Andre Mbongue Mikangue; Elisabeth Zeuko'o Menkem; Juliette Laure Ndzie Ondigui; Ginette Irma Kame-Ngasse; Jeannette Nina Magoudjou-Pekam; Jean Bosco Taya-Fokou; Arnol Bowo-Ngandji; Seraphine Nkie Esemu; Diane Kamdem Thiomo; Paul Moundipa Fewou; Lucy Ndip; Richard Njouom
Journal:  PLoS One       Date:  2022-05-31       Impact factor: 3.752

2.  Trajectories of initiation for the heroin-based drug whoonga - qualitative evidence from South Africa.

Authors:  Griffin A Tyree; Nzwakie Mosery; Elizabeth F Closson; Zonke Mabude; Carol du Toit; David R Bangsberg; Steven A Safren; Kenneth H Mayer; Jennifer A Smit; Matthew J Mimiaga; David J Grelotti
Journal:  Int J Drug Policy       Date:  2020-06-12

3.  Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study.

Authors:  Annie Leprêtre; Idrissa Ba; Karine Lacombe; Maryvonne Maynart; Abdalla Toufik; Ousseynou Ndiaye; Coumba Toure Kane; Joël Gozlan; Judicaël Tine; Ibrahim Ndoye; Gilles Raguin; Pierre-Marie Girard
Journal:  J Int AIDS Soc       Date:  2015-05-22       Impact factor: 5.396

4.  Substance use and universal access to HIV testing and treatment in sub-Saharan Africa: implications and research priorities.

Authors:  Kathryn E Lancaster; Angela Hetrick; Antoine Jaquet; Adebola Adedimeji; Lukoye Atwoli; Donn J Colby; Angel M Mayor; Angela Parcesepe; Jennifer Syvertsen
Journal:  J Virus Erad       Date:  2018-11-15

5.  Research priorities to inform "Treat All" policy implementation for people living with HIV in sub-Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA).

Authors:  Marcel Yotebieng; Ellen Brazier; Diane Addison; April D Kimmel; Morna Cornell; Olivia Keiser; Angela M Parcesepe; Amobi Onovo; Kathryn E Lancaster; Barbara Castelnuovo; Pamela M Murnane; Craig R Cohen; Rachel C Vreeman; Mary-Ann Davies; Stephany N Duda; Constantin T Yiannoutsos; Rose S Bono; Robert Agler; Charlotte Bernard; Jennifer L Syvertsen; Jean d'Amour Sinayobye; Radhika Wikramanayake; Annette H Sohn; Per M von Groote; Gilles Wandeler; Valeriane Leroy; Carolyn F Williams; Kara Wools-Kaloustian; Denis Nash
Journal:  J Int AIDS Soc       Date:  2019-01       Impact factor: 5.396

6.  Anemia Burden, Types and Associated Risk Factors among Kenyan Human Immunodeficiency Virus-1 and Mycobacterium Tuberculosis Co-infected Injection Substance Users.

Authors:  Collins Abonyo; Nathan Shaviya; Valentine Budambula; Tom Were
Journal:  Ethiop J Health Sci       Date:  2020-09

Review 7.  Hepatitis C in HIV-infected individuals: a systematic review and meta-analysis of estimated prevalence in Africa.

Authors:  Tiago Castro Lopes Azevedo; Marcel Zwahlen; Andri Rauch; Matthias Egger; Gilles Wandeler
Journal:  J Int AIDS Soc       Date:  2016-06-09       Impact factor: 5.396
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.